A daily aspirin regimen is known to help reduce risks of heart attack, but researchers found evidence the drug may benefit COPD patients as well.
In a study of COPD sufferers, researchers found that aspirin was linked to fewer moderate exacerbations, but not severe bouts, of the lung disease. It also reduced moderate and severe episodes of labored breathing.
The researchers found the aspirin users had fewer flare-ups over three years. Patients also reported better quality of life and less shortness of breath, compared with patients who did not use aspirin, according to the study.